Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Hypertension Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Hypertension Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Calcium Channel Blockers
      • 1.3.3 Diuretics
      • 1.3.4 Beta Blockers Vasodilators
      • 1.3.5 Angiotensin Converting Enzyme Inhibitors
      • 1.3.6 Alpha Blockers
      • 1.3.7 Angiotensin Receptor Blockers
      • 1.3.8 Renin Inhibitors
    • 1.4 Market Segment by Application
      • 1.4.1 Global Hypertension Drugs Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Hypertension Drugs Market Size
      • 2.1.1 Global Hypertension Drugs Revenue 2014-2025
      • 2.1.2 Global Hypertension Drugs Sales 2014-2025
    • 2.2 Hypertension Drugs Growth Rate by Regions
      • 2.2.1 Global Hypertension Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Hypertension Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Hypertension Drugs Sales by Manufacturers
      • 3.1.1 Hypertension Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Hypertension Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Hypertension Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hypertension Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Hypertension Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Hypertension Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Hypertension Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Hypertension Drugs Market
    • 3.6 Key Manufacturers Hypertension Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Calcium Channel Blockers Sales and Revenue (2014-2019)
      • 4.1.2 Diuretics Sales and Revenue (2014-2019)
      • 4.1.3 Beta Blockers Vasodilators Sales and Revenue (2014-2019)
      • 4.1.4 Angiotensin Converting Enzyme Inhibitors Sales and Revenue (2014-2019)
      • 4.1.5 Alpha Blockers Sales and Revenue (2014-2019)
      • 4.1.6 Angiotensin Receptor Blockers Sales and Revenue (2014-2019)
      • 4.1.7 Renin Inhibitors Sales and Revenue (2014-2019)
    • 4.2 Global Hypertension Drugs Sales Market Share by Type
    • 4.3 Global Hypertension Drugs Revenue Market Share by Type
    • 4.4 Hypertension Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Hypertension Drugs Sales by Application

    6 United States

    • 6.1 United States Hypertension Drugs Breakdown Data by Company
    • 6.2 United States Hypertension Drugs Breakdown Data by Type
    • 6.3 United States Hypertension Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Hypertension Drugs Breakdown Data by Company
    • 7.2 European Union Hypertension Drugs Breakdown Data by Type
    • 7.3 European Union Hypertension Drugs Breakdown Data by Application

    8 China

    • 8.1 China Hypertension Drugs Breakdown Data by Company
    • 8.2 China Hypertension Drugs Breakdown Data by Type
    • 8.3 China Hypertension Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Hypertension Drugs Breakdown Data by Company
    • 9.2 Rest of World Hypertension Drugs Breakdown Data by Type
    • 9.3 Rest of World Hypertension Drugs Breakdown Data by Application
    • 9.4 Rest of World Hypertension Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Hypertension Drugs Sales by Countries
      • 9.4.2 Rest of World Hypertension Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Novartis
      • 10.1.1 Novartis Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Hypertension Drugs
      • 10.1.4 Hypertension Drugs Product Introduction
      • 10.1.5 Novartis Recent Development
    • 10.2 Daiichi Sankyo
      • 10.2.1 Daiichi Sankyo Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Hypertension Drugs
      • 10.2.4 Hypertension Drugs Product Introduction
      • 10.2.5 Daiichi Sankyo Recent Development
    • 10.3 Actelion Pharmaceuticals
      • 10.3.1 Actelion Pharmaceuticals Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Hypertension Drugs
      • 10.3.4 Hypertension Drugs Product Introduction
      • 10.3.5 Actelion Pharmaceuticals Recent Development
    • 10.4 Boehringer Ingelheim
      • 10.4.1 Boehringer Ingelheim Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Hypertension Drugs
      • 10.4.4 Hypertension Drugs Product Introduction
      • 10.4.5 Boehringer Ingelheim Recent Development
    • 10.5 Pfizer
      • 10.5.1 Pfizer Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Hypertension Drugs
      • 10.5.4 Hypertension Drugs Product Introduction
      • 10.5.5 Pfizer Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Hypertension Drugs Sales Channels
      • 11.2.2 Hypertension Drugs Distributors
    • 11.3 Hypertension Drugs Customers

    12 Market Forecast

    • 12.1 Global Hypertension Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Hypertension Drugs Sales Forecast by Type
    • 12.3 Global Hypertension Drugs Sales Forecast by Application
    • 12.4 Hypertension Drugs Forecast by Regions
      • 12.4.1 Global Hypertension Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Hypertension Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These definitions apply to adults who are healthy and not using medication for high blood pressure. If the two pressures fall in different categories, the higher one is used to determine the severity of hypertension.
      With an increase in the population of older people, the market for hypertension drugs has a positive outlook over the forecast period. The prevalence of hypertension is high among the older population with close to 70% of the patients with high BP above the age of 60. Currently, close to 11% of the global population is aged 60 years or over and is estimated to reach nearly 22% by 2050. Since the risk of developing pulmonary hypertension increases with age, a growing older population will aid in the growth prospects of the hypertension drugs market in the coming years. 
      In 2015, the Americas was the largest market for hypertension drugs as it accounted for more than 44% of the market share. The US is the major revenue contributor in the region. The market share is declining due to the patent expiries of drugs such as Micardis, Avapro, and Diovan. However, comorbid conditions among the older population like congenital heart disease and increasing focus on combination therapies will prevent the decline in the market. Moreover, the launch of new disease-modifying therapies is expected to bolster the growth prospects of the market during the forecast period.
      In 2019, the market size of Hypertension Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hypertension Drugs.

      This report studies the global market size of Hypertension Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Hypertension Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Novartis
      Daiichi Sankyo
      Actelion Pharmaceuticals
      Boehringer Ingelheim
      Pfizer
      ...

      Market Segment by Product Type
      Calcium Channel Blockers
      Diuretics
      Beta Blockers Vasodilators
      Angiotensin Converting Enzyme Inhibitors
      Alpha Blockers
      Angiotensin Receptor Blockers
      Renin Inhibitors

      Market Segment by Application
      Hospitals
      Clinics
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Hypertension Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Hypertension Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Hypertension Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now